Leidos Holdings, Inc.
Time frame: 1 December 2022 - 30 November 2023Article ‘Count’ and ‘Share’ for Leidos Holdings, Inc. based on listed parameters only.
The articles listed below published by authors from Leidos Holdings, Inc., organized by journal and article, represent the research output in Count and Share according to the parameters selected above.
Journal | Count | Share |
---|---|---|
ACS Nano |
1 | 0.17 |
American Journal of Human Genetics |
1 | 0.05 |
Angewandte Chemie International Edition |
1 | 0.13 |
Annals of Neurology |
1 | 0.03 |
Blood |
1 | 0.02 |
Cancer Cell |
3 | 0.06 |
Cancer Research |
2 | 0.34 |
Cell |
2 | 0.10 |
Cell Host & Microbe |
1 | 0.01 |
Clinical Infectious Diseases |
1 | 0.06 |
European Urology |
1 | 0.03 |
Gastroenterology |
1 | 0.02 |
Genes & Development |
1 | 0.06 |
Geophysical Research Letters |
1 | 0.07 |
Gut |
1 | 0.04 |
Immunity |
2 | 0.07 |
Journal of Biological Chemistry |
5 | 0.60 |
Journal of Clinical Endocrinology & Metabolism |
1 | 0.06 |
Journal of Clinical Investigation |
1 | 0.05 |
Journal of Clinical Oncology |
1 | 0.05 |
Journal of Infectious Diseases |
6 | 0.44 |
Journal of Neuroscience |
1 | 0.03 |
Journal of the American Chemical Society |
5 | 0.50 |
Journal of the National Cancer Institute |
2 | 0.07 |
Nature |
4 | 0.13 |
Nature Communications |
19 | 0.92 |
Nature Genetics |
1 | 0.08 |
Nature Immunology |
2 | 0.14 |
Nature Medicine |
4 | 0.21 |
Nature Structural & Molecular Biology |
1 | 0.09 |
Organic Letters |
1 | 0.07 |
PLOS Genetics |
1 | 0.20 |
Pediatrics |
1 | 0.09 |
Proceedings of the National Academy of Sciences of the United States of America |
9 | 0.67 |
Science |
1 | 0.03 |
Science Advances |
1 | 0.23 |
The Journal of Allergy and Clinical Immunology |
1 | 0.06 |
The New England Journal of Medicine |
2 | 0.19 |
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.